Showing results 21 to 38 of 38
< previous
Issue Date | Title | Type | Author(s) |
2002 | Leu208Val and Ile181Leu variants of cytochrome P450 CYP2C9 are not related to the acenocoumarol dose requirement in a Spanish population | Articulo | Zarza, J. (José); Hermida, J. (José); Montes, R. (Ramón); Alberca, I. (Ignacio); Lopez, M.L. (María Luz); Rocha, E. (Eduardo) |
2011 | Limited Ability to Activate Protein C Confers Left Atrial Endocardium A Thrombogenic Phenotype: A Role in Cardioembolic Stroke? | Articulo | Cervero, J. (Jorge); Montes, R. (Ramón); España, F. (Francisco); Esmon, C.T. (Charles T.); Hermida, J. (José) |
2009 | Losartan metabolite EXP3179 blocks NADPH oxidase-mediated superoxide production by inhibiting protein kinase C: potential clinical implications in hypertension | Articulo | Fortuño, A. (Ana); Bidegain, J. (J.); Robador, P.A. (Pablo A.); Hermida, J. (José); Lopez-Sagaseta, J. (Jacinto); Beloqui, O. (Óscar); Diez-Martinez, J. (Javier); Zalba, G. (Guillermo) |
2012 | Papel de los polimorfismos de los genes CFH y ARMS2 en el desarrollo de la retinopatía y la cardiopatía isquémica en la diabetes tipo 1 | Articulo | Toni, M. (M.); Hermida, J. (José); Toledo, E. (Estefanía); Goñi, M.J. (M. J.); Diez-Goñi, N. (Nieves) |
2000 | Prevention of renal fibrin deposition in endotoxin-induced DIC through inhibition of PAI-1 | Articulo | Montes, R. (Ramón); Declerck, P.J. (Paul J.); Calvo-González, A. (Alfonso); Montes, M. (Marta); Hermida, J. (José); Muñoz, M.C. (María Carmen); Rocha, E. (Eduardo) |
2012 | Receptor of Activated Protein C Promotes Metastasis and Correlates with Clinical Outcome in Lung Adenocarcinoma | Articulo | Anton, I. (Iker); Molina, E. (Eva); Luis-Ravelo, D. (Diego); Zandueta, C. (Carolina); Valencia, K. (Karmele); Ormazábal, C. (Cristina); Martinez-Canarias, S. (Susana); Perurena, N. (Naiara); Pajares, M.J. (María José); Agorreta, J. (Jackeline); Montuenga-Badia, L.M. (Luis M.); Segura, V. (Víctor); Wistuba, I.I. (Ignacio I.); Rivas, J. (Javier) de las; Hermida, J. (José); Lecanda, F. (Fernando) |
2009 | Recombinant expression of biologically active murine soluble EPCR | Articulo | Lopez-Sagaseta, J. (Jacinto); Montes, R. (Ramón); Hermida, J. (José) |
2002 | Regulation by nitric oxide of endotoxin-induced tissue factor and plasminogen activator inhibitor-1 in endothelial cells | Articulo | Perez-Ruiz, A. (Ana); Montes, R. (Ramón); Velasco, F. (Francisco); Lopez-Pedrera, C. (Chary); Paramo, J.A. (José Antonio); Orbe, J. (Josune); Hermida, J. (José); Rocha, E. (Eduardo) |
2005 | Selective modulation of protein C affinity for EPCR and phospholipids by Gla domain mutation | Articulo | Preston, R.J.S. (Roger J.S.); Villegas-Mendez, A. (Ana); Sun, Y.H. (Yong-Hui); Hermida, J. (José); Simioni, P. (Paolo); Philippou, H. (Helen); Dahlbäck, B. (Björn); Lane, D.A. (David A.) |
2012 | sPLA2-V inhibits EPCR anticoagulant and antiapoptotic properties by accommodating lysophosphatidylcholine or PAF in the hydrophobic groove | Articulo | Lopez-Sagaseta, J. (Jacinto); Puy, C. (Cristina); Tamayo, I. (Ibai); Allende, M. (Mikel); Cervero, J. (Jorge); Velasco, S.E. (Susana E.); Esmon, C.T. (Charles T.); Montes, R. (Ramón); Hermida, J. (José) |
2006 | The c.-1639G > A polymorphism of the VKORC1 gene is a major determinant of the response to acenocoumarol in anticoagulated patients | Articulo | Montes, R. (Ramón); Ruiz-de-Gaona, E. (Estefanía); Martinez-Gonzalez, M.A. (Miguel Ángel); Alberca, I. (Ignacio); Hermida, J. (José) |
2011 | The endothelial cell protein C receptor: its role in thrombosis | Articulo | Navarro, S. (Silvia); Bonet, E. (Elena); Estelles, A. (Amparo); Montes, R. (Ramón); Hermida, J. (José); Martos, L. (Laura); España, F. (Francisco); Medina, P. (Pilar) |
2010 | The endothelial cells downregulate the generation of factor VIIa through EPCR binding | Articulo | Puy, C. (Cristina); Lopez-Sagaseta, J. (Jacinto); Hermida, J. (José); Montes, R. (Ramón) |
2008 | The functional properties of a truncated form of endothelial cell protein C receptor generated by alternative splicing | Articulo | Molina, E. (Eva); Hermida, J. (José); Lopez-Sagaseta, J. (Jacinto); Puy, C. (Cristina); Montes, R. (Ramón) |
2008 | The influence of polymorphisms of VKORC1 and CYP2C9 on major gastrointestinal bleeding risk in anticoagulated patients | Articulo | Montes, R. (Ramón); Nantes, O. (Oscar); Alonso, A. (Alvaro); Zozaya, J.M. (José Manuel); Hermida, J. (José) |
2003 | Tumor necrosis factor-alpha inhibition reduces CXCL-8 levels but fails to prevent fibrin generation and does not improve outcome in a rabbit model of endotoxic shock | Articulo | Rodriguez-Wilhelmi, P. (Pablo); Montes, R. (Ramón); Matsukawa, A. (Akihiro); Nariuchi, H. (Hideo); Hurtado, V. (Verónica); Montes, M. (Marta); Hermida, J. (José); Rocha, E. (Eduardo) |
2012 | Usefulness of high-sensitivity C-reactive protein to predict mortality in patients with atrial fibrillation (from the Atherosclerosis Risk In Communities [ARIC] Study) | Articulo | Hermida, J. (José); Lopez, F.L. (Faye L.); Montes, R. (Ramón); Matsushita, K. (Kunihiro); Astor, B.C. (Brad C.); Alonso, A. (Alvaro) |
31-Dec-2010 | VEGF₁₂₁b and VEGF₁₆₅b are weakly angiogenic isoforms of VEGF-A | Articulo | Catena, R. (R.); Larzabal, L. (Leyre); Larrayoz, M. (Marta); Molina, E. (Eva); Hermida, J. (José); Agorreta, J. (Jackeline); Montes, R. (Ramón); Pio, R. (Rubén); Montuenga-Badia, L.M. (Luis M.); Calvo-González, A. (Alfonso) |